8-K: American Healthcare REIT Exceeds Expectations, Raises Full-Year Guidance After Strong Q2 Performance

American Healthcare REIT reported strong second-quarter results, driven by significant same-store NOI growth, and subsequently increased its full-year 2024 guidance.

Summary

• American Healthcare REIT announced its second quarter 2024 results, showing a GAAP net income of $2.9 million, a significant improvement from a net loss of $(11.9) million in the same period last year.
• The company's Normalized Funds from Operations (NFFO) was $0.33 per diluted share for the quarter.
• Same-Store Net Operating Income (NOI) grew by 15.7% for the total portfolio, with senior housing operating properties (SHOP) and integrated senior health campuses (ISHC) leading with 49.1% and 24.1% growth, respectively.
• Due to better-than-expected operations, the company increased its full-year 2024 total portfolio Same-Store NOI growth guidance by 700 basis points to a range of 12.0% to 14.0%.
• The full-year NFFO guidance was also increased by $0.04 at the midpoint, to a revised range of $1.23 to $1.27 per share.
• The company's Net-Debt-to-Annualized Adjusted EBITDA improved from 6.4x as of March 31, 2024, to 5.9x as of June 30, 2024.
• The company exercised purchase options on three ISHC properties for approximately $45.8 million during the quarter.
• The company has sold approximately $15.6 million of Non-Core Properties during the six months ended June 30, 2024.
• As of June 30, 2024, the company's total Pro-Rata indebtedness was $1.80 billion, with $863.1 million in total consolidated liquidity.
• All Class T and Class I common stock was converted into listed common stock on August 5, 2024.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to the strong financial results, significant growth in key metrics, and upward revisions to full-year guidance. The management's confidence and the company's improved leverage profile further contribute to the high sentiment score.

Positives

• The company achieved a significant turnaround from a net loss to a net income year-over-year.
• The company experienced substantial growth in Same-Store NOI, particularly in the SHOP and ISHC segments.
• The company increased its full-year guidance for both Same-Store NOI growth and NFFO, indicating strong confidence in future performance.
• The company improved its leverage profile, as evidenced by the decrease in Net-Debt-to-Annualized Adjusted EBITDA.
• The company has a strong liquidity position with $863.1 million in total consolidated liquidity.

Negatives

• The outpatient medical segment experienced a slight decline in Same-Store NOI growth, with a decrease of 0.4% for the quarter.
• The increase to NFFO guidance for the year ending December 31, 2024, is partially offset by the increase in interest expense expectations.

Risks

• The company's future performance is subject to various risks and uncertainties, including those disclosed in its filings with the Securities and Exchange Commission.
• The company's ability to achieve its guidance depends on various factors, many of which are outside of its control.
• The company's financial results could be materially impacted by non-recurring and infrequent items that are not indicative of its ongoing operations.
• The company's performance is subject to the demand-supply imbalance present in long-term care.

Future Outlook

The company expects elevated levels of Same-Store NOI growth to persist due to the demand-supply imbalance in long-term care and anticipates continuing to improve its leverage profile with disposition proceeds and incremental earnings growth.

Management Comments

• Danny Prosky, the Company's President and Chief Executive Officer, stated that growth in the first half of 2024 is exceeding expectations, prompting upward revisions to guidance.
• Gabe Willhite, the Company's Chief Operating Officer, believes the company has the opportunity to further enhance pricing power strategies to continue strengthening performance across its ISHC and SHOP segments.
• Brian Peay, the Company's Chief Financial Officer, stated that the robust organic earnings growth has allowed the company to further improve its leverage profile.

Industry Context

The announcement reflects a positive trend in the healthcare real estate sector, with strong demand for senior housing and healthcare facilities driving occupancy and revenue growth. The company's performance is indicative of the broader market dynamics where demand is outpacing supply in long-term care.

Comparison to Industry Standards

• The company's 15.7% same-store NOI growth significantly outperforms the average for healthcare REITs, which typically see growth in the low to mid-single digits.
• Competitors like Welltower (WELL) and Ventas (VTR) have reported same-store NOI growth in the range of 5-8% in recent quarters, making AHR's performance exceptional.
• The 49.1% growth in SHOP properties is particularly noteworthy, as it indicates a strong operational performance in a sector that has faced challenges in recent years.
• The company's improved leverage profile, with a Net-Debt-to-Annualized Adjusted EBITDA of 5.9x, is also favorable compared to some peers that have higher leverage ratios.
• The increase in full-year guidance further sets AHR apart from its peers, demonstrating confidence in its ability to sustain its strong performance.

Stakeholder Impact

• Shareholders will benefit from the increased earnings and improved financial outlook.
• Employees may experience increased job security and potential for career growth due to the company's strong performance.
• Customers and residents of the company's properties may benefit from improved services and facilities.
• Creditors may view the company as a lower-risk borrower due to its improved financial position.

Next Steps

• The company will host a webcast and conference call on August 6, 2024, to discuss the second quarter results.
• The company will continue to market assets for sale, with expected proceeds of approximately $65.0 million for the full year ending December 31, 2024.
• The company anticipates continuing to improve its leverage profile with disposition proceeds and incremental earnings growth.

Key Dates

Keywords

Healthcare REIT, Real Estate Investment Trust, Same-Store NOI, NFFO, Senior Housing, Healthcare Real Estate, Net Operating Income, Adjusted EBITDA, Occupancy, Financial Results